Minimum follow-up time required for the estimation of statistical cure of cancer patients: Verification using data from 42 cancer sites in the SEER database

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Tai, Patricia ^a,h   Yu, Edward ^b   Cserni, Gábor ^c   Vlastos, Georges ^d   Royce, Melanie ^e   Kunkler, Ian ^f   Vinh Hung, Vincent ^g  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Bás Kiskun County Teaching Hospital   (Hungary)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^h Department of Radiation Oncology ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER; CANCER REGISTRY; CANCER SURVIVAL; DATA BASE; DEATH; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PANCREAS CANCER; SALIVARY GLAND CANCER; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; THYROID CANCER; DISEASE FREE SURVIVAL; MORTALITY; NEOPLASM; PROGNOSIS; REGISTER; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MODELS, STATISTICAL; NEOPLASMS; PROGNOSIS; REGISTRIES; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME;

EID: 26844489664     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-48     Document Type: Article

References (34)

1. Feinleib M, McMahon B. Variation in the duration of survival of patients with the chronic leukemias. Blood 1960, 15, 332-349.
2. Kondo K. The log-normal distribution of the incubation time of exogenous diseases. Jpn J Hum Genet 1977, 21, 217-237.
3. Magurran AE. Ecological diversity and its measurement. London, Croom Helm, 1988.
4. Aitchison J, Brown JAC. The Log-normal distribution. Cambridge, UK, Cambridge University Press, 1957.
5. Crow EL, Shimizu K. Log-normal distributions: Theory and application. New York, NY, Dekker, 1988.
6. Lee ET. Statistical Methods for Survival Data Analysis. New York, NY, Wiley, 1992.
7. Johnson NL, Kotz S, Balkrishan N. Continuous univariate distributions. New York, NY, Wiley, 1994.
8. Mould RF, Hearnden T, Palmer M, White G C. Distribution of survival times of 12,000 head and neck cancer patients who died with their disease. Br J Cancer 1976, 34, 180-190.
9. Boag JW. The presentation and analysis of the results of radiotherapy. Part I Introduction. Br J Radiol 1948, 21, 128-138.
10. Boag JW. The presentation and analysis of the results of radiotherapy. Part II. Mathematical theory. Br J Radiol 1948, 21, 189-203.
11. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc [Ser B] 1949, 11, 15-53.
12. Berg JW. The distribution of cancer deaths in time: A survey test of the lognormal model. Br J Cancer 1965, 19, 695-711.
13. Wood CAP, Boag JW. Researches on the radiotherapy of oral cancer. Medical Research Council Special Report 1950; Series No. 267, London: HMSO.
14. Tivey H. The prognosis for survival in chronic granulocytic and lymphocytic leukemia. Am J Roentgenol 1954, 72, 68-93.
15. Haybittle JL. The estimation of the proportion of patients cured after treatment for cancer of the breast. Br J Radiol 1959, 32, 725-733.
16. Mould RF, Lederman M, Tai P, Wong JKM. Methodology to predict long-term survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models. Phys Med Biol 2002, 47, 3893-3924.
17. Tai P, Yu E, Vinh-Hung V, Cserni G, Vlastos G. Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. BMC Cancer 2004, 4, 60.
18. Tai P, Tonita J, Yu E, Skarsgard D. A 20-year follow-up study of the long-term survival of limited stage small cell lung cancer and an overview of prognostic and treatment factors. Int J Radiat Oncol Biol Phys 2003, 56, 626-633.
19. Gamel JW, George SL, Edwards MJ, Seigler HF. The long-term clinical course of patients with cutaneous melanoma. Cancer 2002, 95, 1286-1293.
20. Gamel JW, McLean IW, McCurdy JB. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer 1993, 71, 2299-2305.
21. Mould RF, Boag JW. A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri. Br J Cancer 1975, 32, 529-550.
22. Cutler SJ, Axtell LM. Adjustments of long-term survival rates for deaths due to intercurrent disease. J Chronic Dis 1969, 22, 485-491.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
24. Limpert E, Stahel WA, Abbt M. Log-normal distributions across the sciences: keys and clues. BioScience 2001, 51, 341-352.
25. Surveillance, Epidemiology, and End Results (SEER) program public-use CD-ROM (1973- 1999). Bethesda, Md.: National Cancer Institute, Apr 2002 (software).
26. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993, 85, 979-987.
27. Gamel JW, Vogel RL. Comparison of parametric and non-parametric survival methods using simulated clinical data. Stat Med 1997,16,1629-1643.
28. Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res 2001,10, 339-352.
29. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2001/, 2004.
30. Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Soderman B, Teppo L. Survival of cancer patients in Finland 1955-1994. Acta Oncol 1999, 38 Suppl 12, 1-103.
31. Talback M, Stenbeck M, Rosen M, Barlow L, Glimelius B. Cancer survival in Sweden 1960- 1998 - developments across four decades. Acta Oncol 2003, 42, 637-659.
32. Schairer C, Mink PJ, Carroll L, Devesa SS. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004, 96, 1311-1321.
33. Brenner H, Hakulinen T. Are patients diagnosed with breast cancer before age 50 years ever cured? J Clin Oncol 2004, 22, 432-438.
34. Kerr GR, Kunkler IH, Langlands AO, Rodgert A. (In)curability of breast cancer: a 30-year report of a series of 3933 cases. The Breast 1998, 7, 90-94.